184 related articles for article (PubMed ID: 6981349)
1. Indications for platelet transfusion in children with acute leukemia.
Murphy S; Litwin S; Herring LM; Koch P; Remischovsky J; Donaldson MH; Evans AE; Gardner FH
Am J Hematol; 1982 Jun; 12(4):347-56. PubMed ID: 6981349
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
[TBL] [Abstract][Full Text] [Related]
3. Bleeding due to thrombocytopenia in acute leukemias and reevaluation of the prophylactic platelet transfusion policy.
Aderka D; Praff G; Santo M; Weinberger A; Pinkhas J
Am J Med Sci; 1986 Mar; 291(3):147-51. PubMed ID: 3456706
[TBL] [Abstract][Full Text] [Related]
4. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Rebulla P; Finazzi G; Marangoni F; Avvisati G; Gugliotta L; Tognoni G; Barbui T; Mandelli F; Sirchia G
N Engl J Med; 1997 Dec; 337(26):1870-5. PubMed ID: 9407153
[TBL] [Abstract][Full Text] [Related]
5. New strategies for the optimal use of platelet transfusions.
Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
[TBL] [Abstract][Full Text] [Related]
6. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL.
Heckman KD; Weiner GJ; Davis CS; Strauss RG; Jones MP; Burns CP
J Clin Oncol; 1997 Mar; 15(3):1143-9. PubMed ID: 9060557
[TBL] [Abstract][Full Text] [Related]
7. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
[TBL] [Abstract][Full Text] [Related]
8. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia.
Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D
Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412
[TBL] [Abstract][Full Text] [Related]
9. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
10. An audit of platelet transfusion within the Wellington Cancer Centre.
Buhrkuhl DC; Karlsson MK; Carter JM
Intern Med J; 2012 Jan; 42(1):65-70. PubMed ID: 21040321
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial.
Lye DC; Archuleta S; Syed-Omar SF; Low JG; Oh HM; Wei Y; Fisher D; Ponnampalavanar SSL; Wijaya L; Lee LK; Ooi EE; Kamarulzaman A; Lum LC; Tambyah PA; Leo YS
Lancet; 2017 Apr; 389(10079):1611-1618. PubMed ID: 28283286
[TBL] [Abstract][Full Text] [Related]
12. Potential Harm of Prophylactic Platelet Transfusion in Adult Dengue Patients.
Lee TH; Wong JG; Leo YS; Thein TL; Ng EL; Lee LK; Lye DC
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004576. PubMed ID: 27015272
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic platelet transfusions in children with acute leukemia: a dose response study.
Roy AJ; Jaffe N; Djerassi I
Transfusion; 1973; 13(5):283-90. PubMed ID: 4750180
[No Abstract] [Full Text] [Related]
14. Clinical impact of chemotherapy-induced thrombocytopenia in patients with gynecologic cancer.
Goldberg GL; Gibbon DG; Smith HO; DeVictoria C; Runowicz CD; Burns ER
J Clin Oncol; 1994 Nov; 12(11):2317-20. PubMed ID: 7964946
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of platelet-transfusion therapy administered to patients with acute leukemia.
Kutti J; Zaroulis CG; Dinsmore RE; Reich L; Clarkson BD; Good RA
Transfusion; 1982; 22(1):44-7. PubMed ID: 7064206
[TBL] [Abstract][Full Text] [Related]
16. Platelet transfusion therapy and circulating immune complexes.
Safai-Kutti S; Zaroulis CG; Day NK; Good RA; Kutti J
Vox Sang; 1980 Jul; 39(1):22-7. PubMed ID: 7445473
[TBL] [Abstract][Full Text] [Related]
17. Platelet transfusions and bleeding complications associated with plasma exchange catheter placement in patients with presumed thrombotic thrombocytopenic purpura.
Duffy SM; Coyle TE
J Clin Apher; 2013 Oct; 28(5):356-8. PubMed ID: 23720092
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
[TBL] [Abstract][Full Text] [Related]
19. Platelet transfusion requirements of children with newly diagnosed lymphoblastic leukaemia.
Ilett SJ; Lilleyman JS
Acta Haematol; 1979; 62(2):86-9. PubMed ID: 119406
[TBL] [Abstract][Full Text] [Related]
20. Platelet transfusion therapy in acute leukemia: lack of effect of splenomegaly on transfusion requirements and risk of hemorrhage.
Witzig TE; Ducatman BS; Wick MR; Letendre L; Moore SB; Ilstrup DM; Taswell HF
Am J Hematol; 1985 Apr; 18(4):345-50. PubMed ID: 3976647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
